Wall Street Analysts See an 185.54% Upside in Intellia Therapeutics, Inc. (NTLA): Can the Stock Really Move This High?

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 8.3% over the past four weeks to close the last trading session at $27.18, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $77.61 indicates a potential upside of 185.5%.The average comprises 23 short-term price targets ranging from a low of $29 to a high of $145, with a standard deviation of $29.58. While the lowest estima ...